Vedana Therapeutics
Vedana emerges with $46m funding to advance next-generation migraine therapies
June 26, 2026Research and Development Vedana Therapeutics, migraine therapies
Vedana Therapeutics has emerged from stealth with $46m in Series A financing to support development of a pipeline of investigational …
